CN108368554B - 弥漫性大b细胞淋巴瘤(dlbcl)亚型分型的方法 - Google Patents

弥漫性大b细胞淋巴瘤(dlbcl)亚型分型的方法 Download PDF

Info

Publication number
CN108368554B
CN108368554B CN201680069786.XA CN201680069786A CN108368554B CN 108368554 B CN108368554 B CN 108368554B CN 201680069786 A CN201680069786 A CN 201680069786A CN 108368554 B CN108368554 B CN 108368554B
Authority
CN
China
Prior art keywords
nucleic acid
sample
nppf
dlbcl
tyms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201680069786.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN108368554A (zh
Inventor
B·拉弗勒
Q·刘
J·W·吕克
P·C·罗氏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HTG Molecular Diagnostics Inc
Original Assignee
HTG Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HTG Molecular Diagnostics Inc filed Critical HTG Molecular Diagnostics Inc
Publication of CN108368554A publication Critical patent/CN108368554A/zh
Application granted granted Critical
Publication of CN108368554B publication Critical patent/CN108368554B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201680069786.XA 2015-09-29 2016-09-29 弥漫性大b细胞淋巴瘤(dlbcl)亚型分型的方法 Active CN108368554B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562234491P 2015-09-29 2015-09-29
US62/234,491 2015-09-29
PCT/US2016/054501 WO2017059108A1 (en) 2015-09-29 2016-09-29 Methods for subtyping diffuse b-cell lymphoma (dlbcl)

Publications (2)

Publication Number Publication Date
CN108368554A CN108368554A (zh) 2018-08-03
CN108368554B true CN108368554B (zh) 2022-09-09

Family

ID=57138148

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680069786.XA Active CN108368554B (zh) 2015-09-29 2016-09-29 弥漫性大b细胞淋巴瘤(dlbcl)亚型分型的方法

Country Status (9)

Country Link
US (1) US11384399B2 (https=)
EP (1) EP3356554B1 (https=)
JP (1) JP6836586B2 (https=)
CN (1) CN108368554B (https=)
AU (1) AU2016331058B2 (https=)
BR (1) BR112018006393A2 (https=)
CA (1) CA3000405A1 (https=)
ES (1) ES2765709T3 (https=)
WO (1) WO2017059108A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11696250B2 (en) * 2016-11-09 2023-07-04 Intel Corporation UE and devices for detach handling
EP3638814B8 (en) 2017-06-14 2023-06-21 The United States of America, as Represented by The Secretary, Department of Health and Human Services Method for determining lymphoma type
WO2019036632A1 (en) * 2017-08-18 2019-02-21 Health Research, Inc. COMPOSITIONS AND METHODS FOR DETECTION OF CD30 MRM ISOFORMS FOR USE IN DRUG SELECTION
JP7357921B2 (ja) * 2017-09-29 2023-10-10 国立大学法人九州大学 びまん性大細胞型ｂ細胞リンパ腫患者における化学療法に対する治療効果を予測するための方法及びキット
CA3128973A1 (en) 2019-03-04 2020-09-10 Bhaskar Bhattacharyya Data compression and communication using machine learning
AU2020245086B2 (en) * 2019-03-28 2026-01-08 Centre Henri Becquerel Classification of B-Cell non-Hodgkin Lymphomas
CN111621565B (zh) * 2020-05-07 2023-12-15 杭州可帮基因科技有限公司 弥漫性大b细胞淋巴瘤分子分型试剂盒及分型装置
CN114469949A (zh) * 2020-10-27 2022-05-13 正大天晴药业集团股份有限公司 用于治疗弥漫大b细胞淋巴瘤的喹啉衍生物
CN117987359B (zh) * 2024-02-18 2024-08-30 中源协和生物细胞存储服务(天津)有限公司 用于从生物材料中分离细胞外囊泡的方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010117817A2 (en) * 2009-03-30 2010-10-14 Life Technologies Corporation Methods for generating target specific probes for solution based capture
CN102224255A (zh) * 2008-08-15 2011-10-19 梅里麦克制药股份有限公司 用于预测细胞对治疗剂的应答的方法和系统
CN103649335A (zh) * 2011-05-04 2014-03-19 Htg分子诊断有限公司 定量核酸酶保护测定（qnpa）和测序（qnps）的改进
WO2015069790A1 (en) * 2013-11-06 2015-05-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for subtyping lymphoma types by means expression profiling

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix, Inc. (N.D.Ges.D.Staates Delaware) Verbindungen und ihre Verwendung in einer binären Synthesestrategie
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
WO1995030774A1 (en) 1994-05-05 1995-11-16 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5585069A (en) 1994-11-10 1996-12-17 David Sarnoff Research Center, Inc. Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
GB9624586D0 (en) 1996-11-27 1997-01-15 British Nuclear Fuels Plc Improvements in and relating to coils
US6794499B2 (en) 1997-09-12 2004-09-21 Exiqon A/S Oligonucleotide analogues
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
WO2000037684A1 (en) 1998-12-22 2000-06-29 Kris Richard M High throughput assay system using mass spectrometry
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
US20110152115A1 (en) * 2003-09-03 2011-06-23 The United States of America, as represented by the Secretary, Department of Health and Methods for identifying, diagnosing, and predicting survival of lymphomas
DE102005030336A1 (de) 2005-06-29 2007-01-04 Peri Gmbh Schienengeführtes Klettersystem
EP1963531B1 (en) 2005-12-23 2011-09-21 Nanostring Technologies, Inc. Nanoreporters and methods of manufacturing and use thereof
US20080268451A1 (en) 2007-03-30 2008-10-30 Bruce Seligmann Measurement of an insoluble analyte in a sample
TWI509247B (zh) 2010-03-12 2015-11-21 西建公司 利用雷那度胺（ｌｅｎａｌｉｄｏｍｉｄｅ）治療非霍奇金氏淋巴瘤之方法及作為預測子之基因及蛋白質生物標記

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102224255A (zh) * 2008-08-15 2011-10-19 梅里麦克制药股份有限公司 用于预测细胞对治疗剂的应答的方法和系统
WO2010117817A2 (en) * 2009-03-30 2010-10-14 Life Technologies Corporation Methods for generating target specific probes for solution based capture
CN103649335A (zh) * 2011-05-04 2014-03-19 Htg分子诊断有限公司 定量核酸酶保护测定（qnpa）和测序（qnps）的改进
WO2015069790A1 (en) * 2013-11-06 2015-05-14 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method for subtyping lymphoma types by means expression profiling

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma;George Wright 等;《Proceedings of the national academy of science of the united states of america》;20030819;第100卷(第17期);第9991-9996页 *
Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival;S Blenk等;《Cancer Informatics》;20071212(第3期);第399-420页 *
microRNA与弥漫大B细胞淋巴瘤预后及分型的相关性研究;武鹏艳;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20141231;第e72-48页 *
Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38/07 study;Alexandar Tzankov等;《Journal of hematology & oncology》;20150614;第8卷(第70期);第1-11页 *

Also Published As

Publication number Publication date
AU2016331058B2 (en) 2022-04-07
JP6836586B2 (ja) 2021-03-03
CN108368554A (zh) 2018-08-03
ES2765709T3 (es) 2020-06-10
EP3356554A1 (en) 2018-08-08
EP3356554B1 (en) 2019-10-30
US20180340231A1 (en) 2018-11-29
JP2018536387A (ja) 2018-12-13
BR112018006393A2 (pt) 2018-10-09
US11384399B2 (en) 2022-07-12
CA3000405A1 (en) 2017-04-06
AU2016331058A1 (en) 2018-04-26
WO2017059108A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
CN108368554B (zh) 弥漫性大b细胞淋巴瘤(dlbcl)亚型分型的方法
US12576381B2 (en) Methods and compositions for tagging and analyzing samples
EP4071250B1 (en) Combinatorial dna screening
US9758829B2 (en) Molecular malignancy in melanocytic lesions
AU2013292610B2 (en) System and methods for detecting genetic variation
EP2971284A1 (en) Subtyping lung cancers
JP2007509613A (ja) 遺伝子発現プロファイリングのためのｑＲＴ−ＰＣＲアッセイシステム
EP3358020B1 (en) Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
US20220220546A1 (en) Sherlock assays for tick-borne diseases
CN114269916A (zh) 用于样品分析的装置和方法
US20230235400A1 (en) Methods of detecting mitochondrial diseases
US20120004127A1 (en) Gene expression markers for colorectal cancer prognosis
EP3068906B1 (en) Chromosomal assessment to diagnose urogenital malignancy in dogs
US20260112452A1 (en) Systems and methods for nucleic acid mismatch error detection applications
WO2025222124A1 (en) High-spatial-resolution transcriptional profiling through indexed sequencing

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant